切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (06) : 456 -459. doi: 10.3877/cma.j.issn.1674-3253.2020.06.013

所属专题: 文献

临床研究

成人原发性前列腺肉瘤的临床病理特点及预后
潘金成1, 蒋双键1, 莫承强1, 陈羽1,()   
  1. 1. 510080 广州,中山大学附属第一医院泌尿外科
  • 收稿日期:2020-08-05 出版日期:2020-12-01
  • 通信作者: 陈羽

Clinical characteristics and prognosis of primary prostate sarcoma in adults

Jincheng Pan1, Shuangjian Jiang1, Chengqiang Mo1, Yu Chen1,()   

  1. 1. Department of Urology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
  • Received:2020-08-05 Published:2020-12-01
  • Corresponding author: Yu Chen
  • About author:
    Corresponding author: Chen Yu, Email:
引用本文:

潘金成, 蒋双键, 莫承强, 陈羽. 成人原发性前列腺肉瘤的临床病理特点及预后[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(06): 456-459.

Jincheng Pan, Shuangjian Jiang, Chengqiang Mo, Yu Chen. Clinical characteristics and prognosis of primary prostate sarcoma in adults[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2020, 14(06): 456-459.

目的

探讨前列腺肉瘤的临床表现、影像学特点、病理特征、治疗方法和临床预后。

方法

回顾分析1999年1月至2019年12月收治的12例前列腺肉瘤患者的临床资料,总结分析前列腺肉瘤的临床病理特点,治疗方式及预后。

结果

12例患者均行超声引导下经直肠前列腺穿刺活检,病理结果为前列腺肉瘤,其中横纹肌肉瘤6例,平滑肌肉瘤3例,未分化肉瘤2例,癌肉瘤1例。2例行根治性膀胱前列腺切除术+回肠代膀胱术,5例行根治性前列腺切除术;3例行放化疗;1例仅行化疗,1例仅行前列腺穿刺活检。12例患者除1例仍在随访外均因肿瘤复发转移死亡,平均生存时间15个月(8~25个月)。

结论

前列腺肉瘤恶性程度较高,预后差,超声引导下前列腺穿刺活检和MRI有助于明确诊断,确诊主要依靠病理检查,治疗方法以手术为主,辅以放化疗等综合治疗。

Objective

To investigate the clinical characteristics, imaging and pathological features, treatment and prognosis of primary prostate sarcoma in adults.

Methods

A retrospective analysis was performed on the clinical data of 12 patients with primary prostate sarcoma from January 1999 to December 2019 in the First Affiliated Hospital of Sun Yat-Sen University.

Results

12 patients were diagnosed as prostate sarcoma by trans-rectal ultrasound prostate (TRUS-biopsy), pathological diagnosis revealed that 6 cases with rhabdomyosarcoma, 3 cases with leiomyosarcoma, 2 cases with undifferentiated sarcoma and 1 cases with carcinoid sarcoma. 2 patients received radical cystoprostatectomy and Bricker operation, 5 patients received radical prostatectomy, 2 patients received chemotherapy and radiotherapy, 1 patients received just chemotherapy, 1 patients just underwent prostate biopsy. And postoperative follow-up was performed.They all experienced recurrence and died as a result of disease progression except one patient who is still under follow-up. The average survival time was 15 months.

Conclusion

Prostate sarcoma is rare and highly malignant. The diagnosis is confirmed by TRUS-biopsy and MRI. Surgery remains the main treatment option, chemotherapy and radiotherapy provide therapeutic benefits.

图1 MRI示前列腺肉瘤患者前列腺体积增大
表1 12例前列腺肉瘤患者的临床资料
[1]
Wang X, Liu L, Tang H, et al. Twenty-five cases of adult prostate sarcoma treated at a high-volume institution from 1989 to 2009[J]. J Urol, 2013, 82(1): 160-165.
[2]
Schildhaus H, Lokka S, Fenner W, et al. Spindle cell embryonal rhabdomyosarcoma of the prostate in an adult patient-case report and review of clinicopathological features[J]. Diagn pathol, 2016, 11(1): 56.
[3]
Musser JE, Assel M, Mashni JW, et al. Adult Prostate Sarcoma: The memorial sloan kettering experience[J]. J Urol, 2014, 84(3): 624-628.
[4]
冼土增, 张俊夫, 罗飞, 等. 多参数磁共振成像联合四基因模型提高前列腺癌早期诊断效能的临床研究[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(3): 149-153.
[5]
Alves LJ, Gameiro CD, Lopes S P, et al. Prostate leiomyosarcoma: a rare misleading tumor[J]. J Urol, 2019, 130: 13-16.
[6]
Vandoros GP, Manolidis T, Karamouzis MV, et al. Leiomyosarcoma of the prostate: case report and review of 54 previously published cases[J]. Sarcoma, 2008, 458709.
[7]
Olivas AD, Antic T. Rhabdomyosarcoma of the Adult Prostate: A Case Report With Complete Molecular Profile[J]. Int J Surg Pathol, 2020, 28(1): 92-98.
[8]
毛全宗, 李汉忠, 肖河, 等. 成人前列腺肉瘤的手术方式探讨及疗效分析[J]. 中华泌尿外科杂志, 2016, 37(1): 30-33.
[9]
Sexton W J, Lance R E, Reyes A O, et al. Adult prostate sarcoma: the m. d. anderson cancer center experience[J]. J Urol, 2001, 166(2): 521-525.
[10]
De Bari B, Stish B, Ball M W, et al. Adult prostatic sarcoma: a contemporary multicenter rare cancer network study[J]. Prostate, 2017, 77(10): 1160-1166.
[11]
Ball M W, Sundi D, Reese A C, et al. Multimodal therapy in the treatment of prostate sarcoma: the johns hopkins experience[J]. Clin Genitourin Cancer, 2015, 13(5): 435-440.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[7] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[10] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[11] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[12] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?